These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 34277994)

  • 1. The AGE receptor, OST48 drives podocyte foot process effacement and basement membrane expansion (alters structural composition).
    Zhuang A; Yap FYT; Borg DJ; McCarthy D; Fotheringham A; Leung S; Penfold SA; Sourris KC; Coughlan MT; Schulz BL; Forbes JM
    Endocrinol Diabetes Metab; 2021 Jul; 4(3):e00278. PubMed ID: 34277994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eucalyptol Inhibits Advanced Glycation End Products-Induced Disruption of Podocyte Slit Junctions by Suppressing Rage-Erk-C-Myc Signaling Pathway.
    Kim DY; Kang MK; Lee EJ; Kim YH; Oh H; Kang YH
    Mol Nutr Food Res; 2018 Oct; 62(19):e1800302. PubMed ID: 29987888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FOXO3a accumulation and activation accelerate oxidative stress-induced podocyte injury.
    Chen X; Liu W; Xiao J; Zhang Y; Chen Y; Luo C; Huang Q; Peng F; Gong W; Li S; He X; Zhuang Y; Wu N; Liu Y; Wang Y; Long H
    FASEB J; 2020 Oct; 34(10):13300-13316. PubMed ID: 32786113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Globally elevating the AGE clearance receptor, OST48, does not protect against the development of diabetic kidney disease, despite improving insulin secretion.
    Zhuang A; Yap FYT; McCarthy D; Leung C; Sourris KC; Penfold SA; Thallas-Bonke V; Coughlan MT; Schulz BL; Forbes JM
    Sci Rep; 2019 Sep; 9(1):13664. PubMed ID: 31541173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic kidney lesions of GIPRdn transgenic mice: podocyte hypertrophy and thickening of the GBM precede glomerular hypertrophy and glomerulosclerosis.
    Herbach N; Schairer I; Blutke A; Kautz S; Siebert A; Göke B; Wolf E; Wanke R
    Am J Physiol Renal Physiol; 2009 Apr; 296(4):F819-29. PubMed ID: 19211686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease.
    Tanji N; Markowitz GS; Fu C; Kislinger T; Taguchi A; Pischetsrieder M; Stern D; Schmidt AM; D'Agati VD
    J Am Soc Nephrol; 2000 Sep; 11(9):1656-1666. PubMed ID: 10966490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The receptor for advanced glycation endproducts mediates podocyte heparanase expression through NF-κB signaling pathway.
    An X; Zhang L; Yao Q; Li L; Wang B; Zhang J; He M; Zhang J
    Mol Cell Endocrinol; 2018 Jul; 470():14-25. PubMed ID: 28478303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salvianolic Acid A Protects Against Diabetic Nephropathy through Ameliorating Glomerular Endothelial Dysfunction via Inhibiting AGE-RAGE Signaling.
    Hou B; Qiang G; Zhao Y; Yang X; Chen X; Yan Y; Wang X; Liu C; Zhang L; Du G
    Cell Physiol Biochem; 2017; 44(6):2378-2394. PubMed ID: 29262395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.
    Jha JC; Thallas-Bonke V; Banal C; Gray SP; Chow BS; Ramm G; Quaggin SE; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
    Diabetologia; 2016 Feb; 59(2):379-89. PubMed ID: 26508318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion of protein tyrosine phosphatase SHP-1 restores SUMOylation of podocin and reverses the progression of diabetic kidney disease.
    Lizotte F; Rousseau M; Denhez B; Lévesque D; Guay A; Liu H; Moreau J; Higgins S; Sabbagh R; Susztak K; Boisvert FM; Côté AM; Geraldes P
    Kidney Int; 2023 Oct; 104(4):787-802. PubMed ID: 37507049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of the receptor for advanced glycation end products reduces glomerulosclerosis and preserves renal function in the diabetic OVE26 mouse.
    Reiniger N; Lau K; McCalla D; Eby B; Cheng B; Lu Y; Qu W; Quadri N; Ananthakrishnan R; Furmansky M; Rosario R; Song F; Rai V; Weinberg A; Friedman R; Ramasamy R; D'Agati V; Schmidt AM
    Diabetes; 2010 Aug; 59(8):2043-54. PubMed ID: 20627935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Podocyte-specific VEGF-a gain of function induces nodular glomerulosclerosis in eNOS null mice.
    Veron D; Aggarwal PK; Velazquez H; Kashgarian M; Moeckel G; Tufro A
    J Am Soc Nephrol; 2014 Aug; 25(8):1814-24. PubMed ID: 24578128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The podocyte in diabetic kidney disease.
    Stitt-Cavanagh E; MacLeod L; Kennedy C
    ScientificWorldJournal; 2009 Oct; 9():1127-39. PubMed ID: 19838599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-enzymatic glycation and diabetic kidney disease.
    Pasupulati AK; Nagati V; Paturi ASV; Reddy GB
    Vitam Horm; 2024; 125():251-285. PubMed ID: 38997166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glomerular cell death and inflammation with high-protein diet and diabetes.
    Meek RL; LeBoeuf RC; Saha SA; Alpers CE; Hudkins KL; Cooney SK; Anderberg RJ; Tuttle KR
    Nephrol Dial Transplant; 2013 Jul; 28(7):1711-20. PubMed ID: 23314315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chrysin Inhibits Advanced Glycation End Products-Induced Kidney Fibrosis in Renal Mesangial Cells and Diabetic Kidneys.
    Lee EJ; Kang MK; Kim DY; Kim YH; Oh H; Kang YH
    Nutrients; 2018 Jul; 10(7):. PubMed ID: 29987200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of the formin Diaph1 protects from structural and functional abnormalities in the murine diabetic kidney.
    Manigrasso MB; Friedman RA; Ramasamy R; D'Agati V; Schmidt AM
    Am J Physiol Renal Physiol; 2018 Dec; 315(6):F1601-F1612. PubMed ID: 30132346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FPS-ZM1 and valsartan combination protects better against glomerular filtration barrier damage in streptozotocin-induced diabetic rats.
    Sanajou D; Ghorbani Haghjo A; Argani H; Roshangar L; Ahmad SNS; Jigheh ZA; Aslani S; Panah F; Rashedi J; Mesgari Abbasi M
    J Physiol Biochem; 2018 Aug; 74(3):467-478. PubMed ID: 29948786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Calbindin-D28k in Diabetes-Associated Advanced Glycation End-Products-Induced Renal Proximal Tubule Cell Injury.
    Huang KH; Guan SS; Lin WH; Wu CT; Sheu ML; Chiang CK; Liu SH
    Cells; 2019 Jun; 8(7):. PubMed ID: 31262060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes of podocyte p130Cas in diabetic conditions.
    Ha TS; Choi JY; Park HY; Han GD
    J Nephrol; 2013; 26(5):870-6. PubMed ID: 23559070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.